Indiana Cancer Consortium

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

DESI 2024 VI: cosmological constraints from the measurements of baryon acoustic oscillations

A. G. Adame, José Edgar Madriz Aguilar, S. Ahlen et al. · Journal of Cosmology and Astroparticle Physics · 2025 · 742 citations · Full text

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

Kimberly Blackwell, Harold J. Burstein, Anna Maria Storniolo et al. · Journal of Clinical Oncology · 2012 · 541 citations

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf et al. · Nature Medicine · 2023 · 483 citations · Full text

Hematological Malignancy, Magnetismm-3 Trial Results, Medicine +13

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Panos Fidias, Shaker R. Dakhil, Alan P. Lyss et al. · Journal of Clinical Oncology · 2008 · 421 citations · Full text